Your write up should answer the following questions : How should Medicine$$s Co$.$ price and sell Angiomax? In light of your ensuing go$-$to$-$market strategy, should they pursue FDA approval for low risk patients? Your paper should start with a $1$ paragraph executive summary that states your primary answer to this question. You should make sure to have read the pricing chapter, and potentially review the Marketing Framework chapter from the beginning of the course to help consider your answer. Please note : I am expecting you to generate a specific price and a justification for it based on the information in the case. Your support for your overall marketing plan $($price$,$ strategy, FDA approval$)$ should consider the value proposition of the drug, and the value perceptions of the buyer. As a reminder, you are making this choice based on the time and information in the case, not in the present day.